SPOTLIGHT: Abbott hit with antitrust suit

Pharmacies and a wholesaler slapped Abbott Laboratories with an antitrust lawsuit over the price of its AIDS drug Norvir, which jumped 400 percent in 2003. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.